Lyell Immunopharma
Venture capital · South San Francisco, California, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
2Deep-tech portfolio2 active
0Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: A2 Biotherapeutics
15Co-investorsShare a portfolio company
Portfolio · 2 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| A2 Biotherapeutics | Biotech | Active | Dec 16, 2022 | $118.9M |
| Lyell Immunopharma | Biotech | Active | Mar 20, 2020 | $493.0M |
Peer ranks
Portfolio size#189
Portfolio exits#234
Raises, 12 months#88
Co-investors#133
Co-investors
- Amgen VenturesVenture capital1 shared
- ARCH VentureVenture capital1 shared
- Bessemer Venture PartnersVenture capital1 shared
- Cormorant Asset ManagementVenture capital1 shared
- Foresite CapitalVenture capital1 shared
- GVVenture capital1 shared
- Perceptive AdvisorsVenture capital1 shared
- RA CapitalVenture capital1 shared
- Redmile GroupVenture capital1 shared
- RegeneronVenture capital1 shared
Sectors
- Biotech2
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.